N-acetylcysteine versus AScorbic acid for Preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography:
NASPI study—a prospective randomized controlled trial
To access this article, please choose from the options below
Clinical Trial Identifier: NCT00356954.
This study was supported by a grant from the Innovative Research Institute for Cell Therapy (IRICT: A062260), Republic of Korea, and Clinical Research Center for Ischemic Heart Disease sponsored by the Ministry of Health and Welfare, Republic of Korea (0412-CR02-0704-0001).
PII: S0002-8703(08)01028-4
doi:10.1016/j.ahj.2008.11.010
© 2009 Mosby, Inc. All rights reserved.
